Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Zelluna Immunotherapy has raised €7.5M across 2 funding rounds from 1 investor, most recently a round in Aug 2022. Based in Oslo, Norway; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-08-25 | Other | — | Takeda Ventures | View deal → |
| 2020-12-06 | Other | €7.5M | — | View deal → |
